Jun
Stem Cell Stars Seminar: Chronic myeloid leukemia - We are not yet done
Join us for this afternoon session on 17 June with Dr. Michael Deininger, a leader in the field of blood malignancies!
Lund Stem Cell Center is excited to welcome Michael Deininger, MD, PhD, Chief Scientific Officer Versiti Blood Research Institute based in Milwaukee, Wisconsin, USA and a leader in blood malignancies, at our next Stem Cell Star Seminar.
As a clinician-scientist trained in hematology/oncology as well as molecular biology, Dr. Deininger’s scientific interests have focused on the biology and therapy of leukemia and myeloproliferative neoplasms (MPNs) for more than 20 years. In particular, his efforts have played an important role in multiple clinical studies of MPNs, including chronic myeloid leukemia (CML) that contributed to the establishment of tyrosine kinase inhibitor (TKI) based therapies as the standard of care. Today the Deininger Lab focuses on novel therapeutic targets in leukemia, novel drugs to overcome TKI resistance in CML and other MPNs, and to understand the role of bone marrow microenvironment for leukemogenesis.
- Talk Title: "Chronic myeloid leukemia: We are not yet done"
- When: 17 June, 2024 | 15:00 - 16:00 + mingle
- Where: Belfragesalen, BMC D15
- Host: Professor Göran Karlsson
After the lecture, mingle and connect with colleagues and fellow researchers over refreshments at our post-seminar gathering!
All are welcome, no registration required.
About the event
Location:
Belfragesalen, BMC D15, Klinikgatan 32 in Lund
Target group:
Researchers, scientists, students at Lund University
Language:
In English
Contact:
Claire [dot] Mckay [at] med [dot] lu [dot] se